What is PFGTF stock price today?

PFGTF (Pacific Edge Limited) stock is trading at $0.07 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is PFGTF stock going up or down today?

PFGTF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy PFGTF stock now?

The decision to buy PFGTF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is PFGTF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for PFGTF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is PFGTF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if PFGTF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is PFGTF's P/E ratio?

P/E ratio data for PFGTF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is PFGTF's market cap?

PFGTF (Pacific Edge Limited) has a market capitalization of $0.07 billion, making it a small-cap stock.

What is PFGTF's price to book ratio?

PFGTF trades at a price-to-book (P/B) ratio of 4.51, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does PFGTF pay dividends?

PFGTF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is PFGTF's dividend yield?

PFGTF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is PFGTF stock a good long-term investment?

PFGTF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is PFGTF's revenue growth rate?

PFGTF has shown revenue growth of -0.4% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

PFGTF is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in PFGTF?

Key risks for PFGTF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does PFGTF compare to its competitors?

Compare PFGTF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PFGTF's performance and positioning.

What is PFGTF's stock price target for 2026?

Our AI model provides price targets for PFGTF based on fundamental analysis: Bull case $0.09 (+30%), Base case $0.08 (+15%), Bear case $0.06 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about PFGTF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for PFGTF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is PFGTF's next earnings report?

PFGTF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

PFGTF - Pacific Edge Limited

NYSE * Healthcare * Diagnostics & Research

$0.07

+$0.00 (+0.00%)

About Pacific Edge Limited

Pacific Edge Limited, a cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the detection and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic product that helps de-intensify clinical work-up for patients with haematuria who have a low probability of bladder cancer; and Cxbladder Monitor, a non-invasive surveillance alternative that reduces the burden of repeated cystoscopy in patients with a low risk of recurrence. In addition, the company is developing products for bladder, gastric, colorectal, endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.

PFGTF Key Statistics

Market Cap

$69.82M

P/B Ratio

4.51

EPS

$-0.02

Revenue Growth

-0.4%

Profit Margin

-1.9%

How PFGTF Compares to Peers

PFGTF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
PFGTF(This stock)	$69.82M	N/A	-0%	-1.9%	-
UNHUnitedhealth Group	$322.34B	26.8	0%	0.0%	vs UNH
JNJJohnson &	$547.64B	26.4	0%	0.2%	vs JNJ
LLYEli Lilly	$789.69B	38.5	0%	0.3%	vs LLY
PFEPfizer Inc	$153.59B	19.9	-0%	0.1%	vs PFE
ABBVAbbvie Inc	$351.47B	84.2	0%	0.1%	vs ABBV

Pacific Edge Limited Company Information

Headquarters: Centre for Innovation, Dunedin, New Zealand, 9016, undefined
Website: www.pacificedgedx.com
Sector: Healthcare
Industry: Diagnostics & Research

About Pacific Edge Limited

PFGTF Key Statistics

How PFGTF Compares to Peers

Pacific Edge Limited Company Information

Upcoming Events for PFGTF